Clinical Trials Ver-A-T1D

This known blood pressure lowering drug has been shown recently to protect and strengthen beta cells and slowing down beta cell destruction in T1D.

A second INNODIA trial now started with Verapamil. This known blood pressure lowering drug has been shown recently to protect and strengthen beta cells and slowing down beta cell destruction in T1D. The trial will include 120 patients aged between 18 and 45 years, taking tablets for 1 year.

In this movie, the trial specific information starts at minute 3.

For more Information

Please download the PDF below:

Other Innodia Trials:

How to Participate:

Select country:

Germany
Germany
Denmark
Great Britain
Finland
France
Italy
Italy
Nederlands
Norway
Poland
Sweden
Slovenia
Austria
Belgium
Belgium
Belgium
Belgium
  • Great Britain

    UK - Cardiff

  • Germany - HKA

    Germany - HKA

  • Germany - UULM

    Germany - UULM

  • France - IN-SERM

    France - INSERM

  • Italy UNISI

    Italy - UNISI

  • Italy UniSR

    Italy - UniSR

  • Poland SUM Katowice

    Poland - SUM Katowice

  • Sweden - ULUND

    Sweden - ULUND

  • Austria - MUG

    Austria - MUG

  • Belgium

    Belgium - UZA

  • Belgium

    Belgium - UZLeuven

  • Belgium

    Belgium - ULB

  • Belgium

    Belgium - UZB

Is your country not available?
Send us a mail so we can contact you when the trial starts close to you!

By using this website, you agree to the use of cookies.
For more information visit: Privacy policy